In SLE, the excessive production of autoantibodies and inflammatory cytokines, such as IFN-γ and IL-17, drives widespread inflammation and tissue damage, activating immune pathways that exacerbate thyroid dysfunction [30,38]. This evidence concerns the gene IL17A and systemic lupus erythematosus.